Ab Trill, 10% Owner at DiaMedica Therapeutics Inc. (DMAC), bought 2,122,554 shares at $7.41 ($15.3M) on 2025-11-21, disclosed to the SEC on 2025-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.52 | 187,393 | $1.2M | 8.0% |
| 2 | $6.52 | 187,393 | $1.2M | 8.0% |
| 3 | $6.75 | 182,882 | $1.2M | 8.1% |
| 4 | $6.75 | 182,882 | $1.2M | 8.1% |
| 5 | $7.21 | 240,352 | $1.7M | 11.4% |
| 6 | $7.21 | 240,352 |
| $1.7M |
| 11.4% |
| 7 | $7.41 | 128,426 | $952K | 6.2% |
| 8 | $7.41 | 128,426 | $952K | 6.2% |
| 9 | $7.41 | 208,872 | $1.5M | 10.1% |
| 10 | $7.41 | 208,872 | $1.5M | 10.1% |
| 11 | $7.89 | 40,253 | $318K | 2.1% |
| 12 | $7.89 | 40,253 | $318K | 2.1% |
| 13 | $8.57 | 73,099 | $626K | 4.1% |
| 14 | $8.57 | 73,099 | $626K | 4.1% |
| Total | $7.19 avg | 2,122,554 | $15.3M | 100% |